ReP USP - Resultado da busca

Artigo de periodico
Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations (2022)
Soares, Kelen Carine Costa; Chiann, Chang ; Storpirtis, Silvia
Source: European Journal of Pharmaceutical Sciences. Unidades: IME, FCF
Subjects: BIOEQUIVALÊNCIA, ANÁLISE DE SÉRIES TEMPORAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Kelen Carine Costa e CHIANN, Chang e STORPIRTIS, Silvia. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations. European Journal of Pharmaceutical Sciences, v. 171, n. artigo 106127, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2022.106127. Acesso em: 08 nov. 2024.
APA
Soares, K. C. C., Chiann, C., & Storpirtis, S. (2022). Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations. European Journal of Pharmaceutical Sciences, 171( artigo 106127), 1-6. doi:10.1016/j.ejps.2022.106127
NLM
Soares KCC, Chiann C, Storpirtis S. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 171( artigo 106127): 1-6.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejps.2022.106127
Vancouver
Soares KCC, Chiann C, Storpirtis S. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 171( artigo 106127): 1-6.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejps.2022.106127
Artigo de periodico
A broad view of pharmaceutical services in multidisciplinary teams of public Primary Healthcare Centers: a mixed methods study in a large city in Brazil (2022)
Mendes, Samara Jamile ; Farisco, Myllena ; Leite, Silvana Nair ; Storpirtis, Silvia
Source: Primary Health Care Research & Developmente. Unidades: FCF, ESALQ
Subjects: ATENÇÃO PRIMÁRIA À SAÚDE, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDES, Samara Jamile et al. A broad view of pharmaceutical services in multidisciplinary teams of public Primary Healthcare Centers: a mixed methods study in a large city in Brazil. Primary Health Care Research & Developmente, v. 23, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1017/S1463423622000160. Acesso em: 08 nov. 2024.
APA
Mendes, S. J., Farisco, M., Leite, S. N., & Storpirtis, S. (2022). A broad view of pharmaceutical services in multidisciplinary teams of public Primary Healthcare Centers: a mixed methods study in a large city in Brazil. Primary Health Care Research & Developmente, 23, 1-7. doi:10.1017/S1463423622000160
NLM
Mendes SJ, Farisco M, Leite SN, Storpirtis S. A broad view of pharmaceutical services in multidisciplinary teams of public Primary Healthcare Centers: a mixed methods study in a large city in Brazil [Internet]. Primary Health Care Research & Developmente. 2022 ; 23 1-7.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1017/S1463423622000160
Vancouver
Mendes SJ, Farisco M, Leite SN, Storpirtis S. A broad view of pharmaceutical services in multidisciplinary teams of public Primary Healthcare Centers: a mixed methods study in a large city in Brazil [Internet]. Primary Health Care Research & Developmente. 2022 ; 23 1-7.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1017/S1463423622000160
Artigo de periodico
N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir (2020)
Tavares, Guilherme Diniz; Gonçalves, José Eduardo; Monteiro, Lis Marie ; Löbenberg, Raimar ; Storpirtis, Silvia ; Bou-Chacra, Nadia Araci ; Consiglieri, Vladi Olga
Source: Colloids and Surfaces B. Unidade: FCF
Subjects: NANOPARTÍCULAS, QUITOSANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Guilherme Diniz et al. N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir. Colloids and Surfaces B, v. 196, p. 1-9 art. 111336, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2020.111336. Acesso em: 08 nov. 2024.
APA
Tavares, G. D., Gonçalves, J. E., Monteiro, L. M., Löbenberg, R., Storpirtis, S., Bou-Chacra, N. A., & Consiglieri, V. O. (2020). N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir. Colloids and Surfaces B, 196, 1-9 art. 111336. doi:10.1016/j.colsurfb.2020.111336
NLM
Tavares GD, Gonçalves JE, Monteiro LM, Löbenberg R, Storpirtis S, Bou-Chacra NA, Consiglieri VO. N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir [Internet]. Colloids and Surfaces B. 2020 ; 196 1-9 art. 111336.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111336
Vancouver
Tavares GD, Gonçalves JE, Monteiro LM, Löbenberg R, Storpirtis S, Bou-Chacra NA, Consiglieri VO. N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir [Internet]. Colloids and Surfaces B. 2020 ; 196 1-9 art. 111336.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111336
Artigo de periodico-carta/editorial
Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" (2020)
Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo ; Storpirtis, Silvia
Source: Research in Social and Administrative Pharmacy. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Tácio de Mendonça e AGUIAR, Patrícia Melo e STORPIRTIS, Silvia. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients". Research in Social and Administrative Pharmacy. New York: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.sapharm.2019.12.017. Acesso em: 08 nov. 2024. , 2020
APA
Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2020). Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients". Research in Social and Administrative Pharmacy. New York: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1016/j.sapharm.2019.12.017
NLM
Lima T de M, Aguiar PM, Storpirtis S. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" [Internet]. Research in Social and Administrative Pharmacy. 2020 ; 16( 3): 434-435.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.sapharm.2019.12.017
Vancouver
Lima T de M, Aguiar PM, Storpirtis S. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" [Internet]. Research in Social and Administrative Pharmacy. 2020 ; 16( 3): 434-435.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.sapharm.2019.12.017
Artigo de periodico
Development and validation of key performance indicators for medication management services provided for outpatients (2019)
Lima, Tácio de Mendonça ; Aguiar, Patricia Melo ; Storpirtis, Silvia
Source: Research in Social and Administrative Pharmacy. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Tácio de Mendonça e AGUIAR, Patricia Melo e STORPIRTIS, Silvia. Development and validation of key performance indicators for medication management services provided for outpatients. Research in Social and Administrative Pharmacy, v. 15, n. 9, p. 1080-1087, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2018.09.010. Acesso em: 08 nov. 2024.
APA
Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2019). Development and validation of key performance indicators for medication management services provided for outpatients. Research in Social and Administrative Pharmacy, 15( 9), 1080-1087. doi:10.1016/j.sapharm.2018.09.010
NLM
Lima T de M, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients [Internet]. Research in Social and Administrative Pharmacy. 2019 ; 15( 9): 1080-1087.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.sapharm.2018.09.010
Vancouver
Lima T de M, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients [Internet]. Research in Social and Administrative Pharmacy. 2019 ; 15( 9): 1080-1087.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.sapharm.2018.09.010
Artigo de periodico
Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study (2019)
Scarabelin, Aline; Dósea, Aline Santana; Aguiar, Patrícia Melo ; Storpirtis, Silvia
Source: Journal of Patient Experience. Unidade: FCF
Subjects: NEOPLASIAS PROSTÁTICAS, ASSISTÊNCIA À SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCARABELIN, Aline et al. Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study. Journal of Patient Experience, v. 6, n. 2, p. 150-156, 2019Tradução . . Disponível em: https://doi.org/10.1177/2374373518786508. Acesso em: 08 nov. 2024.
APA
Scarabelin, A., Dósea, A. S., Aguiar, P. M., & Storpirtis, S. (2019). Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study. Journal of Patient Experience, 6( 2), 150-156. doi:10.1177/2374373518786508
NLM
Scarabelin A, Dósea AS, Aguiar PM, Storpirtis S. Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study [Internet]. Journal of Patient Experience. 2019 ; 6( 2): 150-156.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1177/2374373518786508
Vancouver
Scarabelin A, Dósea AS, Aguiar PM, Storpirtis S. Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study [Internet]. Journal of Patient Experience. 2019 ; 6( 2): 150-156.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1177/2374373518786508
Artigo de periodico
Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial (2018)
Aguiar, Patrícia Melo ; Silva, Cláudio Henrique P. da; Chiann, Chang ; Dórea, Egídio Lima; Lyra Júnior, Divaldo Pereira de; Storpirtis, Silvia
Source: Journal of Evaluation in Clinical Practice. Unidades: IME, HU, FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, FARMACÊUTICOS, MULTIDISCIPLINARIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Patrícia Melo et al. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. Journal of Evaluation in Clinical Practice, v. 24, n. 1, p. 22-30, 2018Tradução . . Disponível em: https://doi.org/10.1111/jep.12606. Acesso em: 08 nov. 2024.
APA
Aguiar, P. M., Silva, C. H. P. da, Chiann, C., Dórea, E. L., Lyra Júnior, D. P. de, & Storpirtis, S. (2018). Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. Journal of Evaluation in Clinical Practice, 24( 1), 22-30. doi:10.1111/jep.12606
NLM
Aguiar PM, Silva CHP da, Chiann C, Dórea EL, Lyra Júnior DP de, Storpirtis S. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial [Internet]. Journal of Evaluation in Clinical Practice. 2018 ; 24( 1): 22-30.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/jep.12606
Vancouver
Aguiar PM, Silva CHP da, Chiann C, Dórea EL, Lyra Júnior DP de, Storpirtis S. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial [Internet]. Journal of Evaluation in Clinical Practice. 2018 ; 24( 1): 22-30.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/jep.12606
Artigo de periodico
Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews (2018)
Ribeiro, Esther Letícia Amorim; Lima, Tácio de Mendonça; Vieira, Márcio Eduardo Bergamini; Storpirtis, Silvia ; Aguiar, Patrícia Melo
Source: European Journal of Clinical Pharmacology. Unidades: HU, FCF
Subjects: ANTIPSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Esther Letícia Amorim et al. Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews. European Journal of Clinical Pharmacology, v. 74, n. 10, p. 1215-1233, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00228-018-2498-1. Acesso em: 08 nov. 2024.
APA
Ribeiro, E. L. A., Lima, T. de M., Vieira, M. E. B., Storpirtis, S., & Aguiar, P. M. (2018). Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews. European Journal of Clinical Pharmacology, 74( 10), 1215-1233. doi:10.1007/s00228-018-2498-1
NLM
Ribeiro ELA, Lima T de M, Vieira MEB, Storpirtis S, Aguiar PM. Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews [Internet]. European Journal of Clinical Pharmacology. 2018 ; 74( 10): 1215-1233.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s00228-018-2498-1
Vancouver
Ribeiro ELA, Lima T de M, Vieira MEB, Storpirtis S, Aguiar PM. Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews [Internet]. European Journal of Clinical Pharmacology. 2018 ; 74( 10): 1215-1233.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s00228-018-2498-1
Artigo de periodico
Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis (2018)
Lima, Tácio de Mendonça; Aguiar, Patrícia Melo ; Storpirtis, Silvia
Source: Research in Social and Administrative Pharmacy. Unidade: FCF
Subjects: SERVIÇOS DE SAÚDE, PSICOMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Tácio de Mendonça e AGUIAR, Patrícia Melo e STORPIRTIS, Silvia. Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis. Research in Social and Administrative Pharmacy, v. 14, n. 5, p. 405-412, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2017.05.011. Acesso em: 08 nov. 2024.
APA
Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2018). Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis. Research in Social and Administrative Pharmacy, 14( 5), 405-412. doi:10.1016/j.sapharm.2017.05.011
NLM
Lima T de M, Aguiar PM, Storpirtis S. Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis [Internet]. Research in Social and Administrative Pharmacy. 2018 ; 14( 5): 405-412.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.sapharm.2017.05.011
Vancouver
Lima T de M, Aguiar PM, Storpirtis S. Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis [Internet]. Research in Social and Administrative Pharmacy. 2018 ; 14( 5): 405-412.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.sapharm.2017.05.011
Parte de monografia/livro
Bioequivalence requirements in various global jurisdictions (2017)
Cristofoletti, Rodrigo; Marques, Margareth Rita de Cassia; Storpirtis, Silvia
Source: Bioequivalence Requirements in Various Global Jurisdictions. Unidade: FCF
Assunto: BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRISTOFOLETTI, Rodrigo e MARQUES, Margareth Rita de Cassia e STORPIRTIS, Silvia. Bioequivalence requirements in various global jurisdictions. Bioequivalence Requirements in Various Global Jurisdictions. Tradução . Heidelberg: Springer, 2017. . . Acesso em: 08 nov. 2024.
APA
Cristofoletti, R., Marques, M. R. de C., & Storpirtis, S. (2017). Bioequivalence requirements in various global jurisdictions. In Bioequivalence Requirements in Various Global Jurisdictions. Heidelberg: Springer.
NLM
Cristofoletti R, Marques MR de C, Storpirtis S. Bioequivalence requirements in various global jurisdictions. In: Bioequivalence Requirements in Various Global Jurisdictions. Heidelberg: Springer; 2017. [citado 2024 nov. 08 ]
Vancouver
Cristofoletti R, Marques MR de C, Storpirtis S. Bioequivalence requirements in various global jurisdictions. In: Bioequivalence Requirements in Various Global Jurisdictions. Heidelberg: Springer; 2017. [citado 2024 nov. 08 ]
Artigo de periodico
The effects of pharmacist interventions on adult outpatients with cancer: a systematic review (2017)
Colombo, L. R. P; Aguiar, Patrícia Melo ; Lima, T M; Storpirtis, Silvia
Source: Journal of Clinical Pharmacy and Therapeutics. Unidade: FCF
Subjects: NEOPLASIAS, ASSISTÊNCIA À SAÚDE, FARMACÊUTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLOMBO, L. R. P et al. The effects of pharmacist interventions on adult outpatients with cancer: a systematic review. Journal of Clinical Pharmacy and Therapeutics, v. 42, p. 414–424, 2017Tradução . . Disponível em: https://doi.org/10.1111/jcpt.12562. Acesso em: 08 nov. 2024.
APA
Colombo, L. R. P., Aguiar, P. M., Lima, T. M., & Storpirtis, S. (2017). The effects of pharmacist interventions on adult outpatients with cancer: a systematic review. Journal of Clinical Pharmacy and Therapeutics, 42, 414–424. doi:10.1111/jcpt.12562
NLM
Colombo LRP, Aguiar PM, Lima TM, Storpirtis S. The effects of pharmacist interventions on adult outpatients with cancer: a systematic review [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2017 ; 42 414–424.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/jcpt.12562
Vancouver
Colombo LRP, Aguiar PM, Lima TM, Storpirtis S. The effects of pharmacist interventions on adult outpatients with cancer: a systematic review [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2017 ; 42 414–424.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/jcpt.12562
Artigo de periodico
Potentially inappropriate prescribing and associated factors in elderly patients at hospital discharge in Brazil: a cross-sectional study (2017)
Mori, Ana Luiza Pereira Moreira; Carvalho, Renata Cunha; Aguiar, Patrícia Melo ; Lima, Maria Goretti Farias de ; Rossi, Magali da Silva Pacheco Nobre ; Carrillo, José Fernando Salvador; Dórea, Egídio Lima; Storpirtis, Silvia
Source: International Journal of Clinical Pharmacy. Unidades: FCF, HU
Subjects: ERROS DE MEDICAÇÃO, MEDICAMENTO, ERROS DE MEDICAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Ana Luiza Pereira Moreira et al. Potentially inappropriate prescribing and associated factors in elderly patients at hospital discharge in Brazil: a cross-sectional study. International Journal of Clinical Pharmacy, v. 39, n. 2, p. 386-393, 2017Tradução . . Disponível em: https://doi.org/10.1007/s11096-017-0433-7. Acesso em: 08 nov. 2024.
APA
Mori, A. L. P. M., Carvalho, R. C., Aguiar, P. M., Lima, M. G. F. de, Rossi, M. da S. P. N., Carrillo, J. F. S., et al. (2017). Potentially inappropriate prescribing and associated factors in elderly patients at hospital discharge in Brazil: a cross-sectional study. International Journal of Clinical Pharmacy, 39( 2), 386-393. doi:10.1007/s11096-017-0433-7
NLM
Mori ALPM, Carvalho RC, Aguiar PM, Lima MGF de, Rossi M da SPN, Carrillo JFS, Dórea EL, Storpirtis S. Potentially inappropriate prescribing and associated factors in elderly patients at hospital discharge in Brazil: a cross-sectional study [Internet]. International Journal of Clinical Pharmacy. 2017 ; 39( 2): 386-393.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11096-017-0433-7
Vancouver
Mori ALPM, Carvalho RC, Aguiar PM, Lima MGF de, Rossi M da SPN, Carrillo JFS, Dórea EL, Storpirtis S. Potentially inappropriate prescribing and associated factors in elderly patients at hospital discharge in Brazil: a cross-sectional study [Internet]. International Journal of Clinical Pharmacy. 2017 ; 39( 2): 386-393.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11096-017-0433-7
Artigo de periodico
Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses (2017)
Aguiar, Patrícia Melo ; Lima, Tácio de Mendonça; Colleoni, Gisele Wally Braga; Storpirtis, Silvia
Source: Critical Reviews in Oncology Hematology. Unidade: FCF
Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Patrícia Melo et al. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, v. 113, p. 195-212, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.critrevonc.2017.03.014. Acesso em: 08 nov. 2024.
APA
Aguiar, P. M., Lima, T. de M., Colleoni, G. W. B., & Storpirtis, S. (2017). Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, 113, 195-212. doi:10.1016/j.critrevonc.2017.03.014
NLM
Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014
Vancouver
Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014
Artigo de periodico
Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? (2016)
Aguiar, Patrícia Melo ; Lima, T M; Storpirtis, Silvia
Source: Journal of Clinical Pharmacy and Therapeutics. Unidade: FCF
Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Patrícia Melo e LIMA, T M e STORPIRTIS, Silvia. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?. Journal of Clinical Pharmacy and Therapeutics, v. 41, n. 2, p. 189-197, 2016Tradução . . Disponível em: https://doi.org/10.1111/jcpt.12384. Acesso em: 08 nov. 2024.
APA
Aguiar, P. M., Lima, T. M., & Storpirtis, S. (2016). Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? Journal of Clinical Pharmacy and Therapeutics, 41( 2), 189-197. doi:10.1111/jcpt.12384
NLM
Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/jcpt.12384
Vancouver
Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/jcpt.12384
Artigo de periodico
Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis (2016)
Aguiar, Patrícia Melo ; Brito, Giselle de Carvalho; Lima, Tácio de Mendonça; Santos, Ana Patrícia Alves Lima; Lyra Júnior, Divaldo Pereira de; Storpirtis, Silvia
Source: PLOS ONE. Unidade: FCF
Subjects: GLICEMIA, DIABETES MELLITUS, ASSISTÊNCIA AO PACIENTE (SERVIÇOS DE SAÚDE), FARMACÊUTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Patrícia Melo et al. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis. PLOS ONE, v. 11, n. 3, p. 1-23 art. e0150999, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0150999. Acesso em: 08 nov. 2024.
APA
Aguiar, P. M., Brito, G. de C., Lima, T. de M., Santos, A. P. A. L., Lyra Júnior, D. P. de, & Storpirtis, S. (2016). Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis. PLOS ONE, 11( 3), 1-23 art. e0150999. doi:10.1371/journal.pone.0150999
NLM
Aguiar PM, Brito G de C, Lima T de M, Santos APAL, Lyra Júnior DP de, Storpirtis S. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis [Internet]. PLOS ONE. 2016 ; 11( 3): 1-23 art. e0150999.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1371/journal.pone.0150999
Vancouver
Aguiar PM, Brito G de C, Lima T de M, Santos APAL, Lyra Júnior DP de, Storpirtis S. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis [Internet]. PLOS ONE. 2016 ; 11( 3): 1-23 art. e0150999.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1371/journal.pone.0150999
Artigo de periodico
Development and characterization of ketoconazole cream to treat superficial mycoses: in vitro permeation and in vivo retention studies (2015)
Freitas, Zaida Maria Faria de; Ricci Júnior, Eduardo; Bemvindo, Carolina; Santos, Elisabete Pereira dos; Storpirtis, Silvia ; Chiann, Chang ; Volpato, Nádia Maria
Source: Latin American Journal of Pharmacy. Unidades: FCF, IME
Subjects: ESTATÍSTICA, FARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Zaida Maria Faria de et al. Development and characterization of ketoconazole cream to treat superficial mycoses: in vitro permeation and in vivo retention studies. Latin American Journal of Pharmacy, v. 34, n. 7, p. 1304-1310, 2015Tradução . . Acesso em: 08 nov. 2024.
APA
Freitas, Z. M. F. de, Ricci Júnior, E., Bemvindo, C., Santos, E. P. dos, Storpirtis, S., Chiann, C., & Volpato, N. M. (2015). Development and characterization of ketoconazole cream to treat superficial mycoses: in vitro permeation and in vivo retention studies. Latin American Journal of Pharmacy, 34( 7), 1304-1310.
NLM
Freitas ZMF de, Ricci Júnior E, Bemvindo C, Santos EP dos, Storpirtis S, Chiann C, Volpato NM. Development and characterization of ketoconazole cream to treat superficial mycoses: in vitro permeation and in vivo retention studies. Latin American Journal of Pharmacy. 2015 ; 34( 7): 1304-1310.[citado 2024 nov. 08 ]
Vancouver
Freitas ZMF de, Ricci Júnior E, Bemvindo C, Santos EP dos, Storpirtis S, Chiann C, Volpato NM. Development and characterization of ketoconazole cream to treat superficial mycoses: in vitro permeation and in vivo retention studies. Latin American Journal of Pharmacy. 2015 ; 34( 7): 1304-1310.[citado 2024 nov. 08 ]
Artigo de periodico
Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA) (2015)
Fernandes, Mariane Ballerini; Gonçalves, José Eduardo; Tavares, Leoberto Costa ; Storpirtis, Silvia
Source: Drug Development and Industrial Pharmacy. Unidade: FCF
Subjects: ANTI-INFECCIOSOS, BIOFARMÁCIA, RESISTÊNCIA MICROBIANA ÀS DROGAS, STAPHYLOCOCCUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Mariane Ballerini et al. Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA). Drug Development and Industrial Pharmacy, v. 41, n. 7, p. 1066-1072, 2015Tradução . . Disponível em: https://doi.org/10.3109/03639045.2014.925919. Acesso em: 08 nov. 2024.
APA
Fernandes, M. B., Gonçalves, J. E., Tavares, L. C., & Storpirtis, S. (2015). Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA). Drug Development and Industrial Pharmacy, 41( 7), 1066-1072. doi:10.3109/03639045.2014.925919
NLM
Fernandes MB, Gonçalves JE, Tavares LC, Storpirtis S. Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA) [Internet]. Drug Development and Industrial Pharmacy. 2015 ; 41( 7): 1066-1072.[citado 2024 nov. 08 ] Available from: https://doi.org/10.3109/03639045.2014.925919
Vancouver
Fernandes MB, Gonçalves JE, Tavares LC, Storpirtis S. Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA) [Internet]. Drug Development and Industrial Pharmacy. 2015 ; 41( 7): 1066-1072.[citado 2024 nov. 08 ] Available from: https://doi.org/10.3109/03639045.2014.925919
Artigo de periodico
Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity (2014)
Serafim, Ricardo Augusto Massarico; Gonçalves, José Eduardo; Souza, Felipe Pereira de; Loureiro, Ana Paula de Melo ; Storpirtis, Silvia ; Krogh, Renata; Andricopulo, Adriano Defini ; Dias, Luiz Carlos; Ferreira, Elizabeth Igne
Source: European Journal of Medicinal Chemistry. Unidades: FCF, IFSC
Subjects: TRYPANOSOMA CRUZI, INIBIDORES DE ENZIMAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Ricardo Augusto Massarico et al. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. European Journal of Medicinal Chemistry, v. 82, p. 418-425, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2014.05.077. Acesso em: 08 nov. 2024.
APA
Serafim, R. A. M., Gonçalves, J. E., Souza, F. P. de, Loureiro, A. P. de M., Storpirtis, S., Krogh, R., et al. (2014). Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. European Journal of Medicinal Chemistry, 82, 418-425. doi:10.1016/j.ejmech.2014.05.077
NLM
Serafim RAM, Gonçalves JE, Souza FP de, Loureiro AP de M, Storpirtis S, Krogh R, Andricopulo AD, Dias LC, Ferreira EI. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity [Internet]. European Journal of Medicinal Chemistry. 2014 ; 82 418-425.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejmech.2014.05.077
Vancouver
Serafim RAM, Gonçalves JE, Souza FP de, Loureiro AP de M, Storpirtis S, Krogh R, Andricopulo AD, Dias LC, Ferreira EI. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity [Internet]. European Journal of Medicinal Chemistry. 2014 ; 82 418-425.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejmech.2014.05.077
Artigo de periodico
Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview (2014)
Aguiar, Patrícia Melo ; Brito, Giselle de Carvalho; Correr, Cassyano Januario; Lyra Júnior, Divaldo Pereira de; Storpirtis, Silvia
Source: Annals of Pharmacotherapy. Unidade: FCF
Subjects: DIABETES MELLITUS, SERVIÇOS FARMACÊUTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Patrícia Melo et al. Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview. Annals of Pharmacotherapy, v. 48, n. 7, p. 887-896, 2014Tradução . . Disponível em: https://doi.org/10.1177/1060028014529411. Acesso em: 08 nov. 2024.
APA
Aguiar, P. M., Brito, G. de C., Correr, C. J., Lyra Júnior, D. P. de, & Storpirtis, S. (2014). Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview. Annals of Pharmacotherapy, 48( 7), 887-896. doi:10.1177/1060028014529411
NLM
Aguiar PM, Brito G de C, Correr CJ, Lyra Júnior DP de, Storpirtis S. Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview [Internet]. Annals of Pharmacotherapy. 2014 ; 48( 7): 887-896.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1177/1060028014529411
Vancouver
Aguiar PM, Brito G de C, Correr CJ, Lyra Júnior DP de, Storpirtis S. Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview [Internet]. Annals of Pharmacotherapy. 2014 ; 48( 7): 887-896.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1177/1060028014529411
Artigo de periodico
A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies (2013)
Cristofoletti, Rodrigo; Chiann, Chang ; Dressman, Jennifer B; Storpirtis, Silvia
Source: Journal of Pharmaceutical Sciences. Unidades: IME, FCF
Subjects: BIOEQUIVALÊNCIA, SOLUBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRISTOFOLETTI, Rodrigo et al. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, v. 102, n. 9, p. 3136-3144, 2013Tradução . . Disponível em: https://doi.org/10.1002/jps.23515. Acesso em: 08 nov. 2024.
APA
Cristofoletti, R., Chiann, C., Dressman, J. B., & Storpirtis, S. (2013). A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, 102( 9), 3136-3144. doi:10.1002/jps.23515
NLM
Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1002/jps.23515
Vancouver
Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1002/jps.23515

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration